Skip to Main Content

Paper Details

Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
Ann Hematol
3
2021
Author NameAffiliation
Rodrigo DienstmannVall d'Hebron Institute of Oncology (VHIO)
  • 1 - 1

Datasets

Release 1.2